Editor's note: This article was originally published in CIDRAP News as a seven-part series running from October 25 through November 2, 2007. It investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) today confirmed 20 more swine influenza cases, all connected to previous cases at a New York City high school, and said federal officials will issue new travel advice urging against nonessential travel to Mexico.
(CIDRAP News) On the heels of yesterday's pandemic declaration by the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC) today urged businesses to review their pandemic plans to make sure they're flexible enough to respond to a moderate or severe pandemic.
(CIDRAP News) Responding to lobbying by the Obama administration and public health advocates, Congress last week approved $7.65 billion for battling pandemic influenza, more than three times what the House and Senate had earlier proposed.
(CIDRAP News) The Institute of Medicine (IOM) today affirmed existing federal guidance that healthcare workers caring for H1N1 influenza patients should wear fit-tested N95 respirators, not just surgical masks, to protect them from the virus.
(CIDRAP News) With the health of small businesses at stake in fragile economic times, federal officials and one of the nation's top business groups pushed new efforts this week to help companies prepare for the next wave of the H1N1 pandemic influenza.
(CIDRAP News) With the second wave of the H1N1 influenza virus now hitting, much of the response toe the pandemic is focused on the development and distribution of an effective vaccine, a project that poses many challenges and uncertainties.
Sept 23, 2009 (CIDRAP News) To mask or not to mask, hand washing versus hand sanitizers, how long to stay away from the workplace if sick with novel H1N1 influenza, tips for travelthese were some of the issues addressed in a panel discussion yesterday during a business preparedness summit in Minneapolis.